Document 3130 DOCN M94A3130 TI HIV infection in women in Argentina five years observational study. DT 9412 AU Lupo S; Santarelli MT; Kneitschel R; Bortolozzi R; Navarret N; Taborda M; Hospital Centenario, University of Rosario, Argentina. SO Int Conf AIDS. 1994 Aug 7-12;10(1):147 (abstract no. PB0013). Unique Identifier : AIDSLINE ICA10/94369445 AB OBJECTIVE: to describe the epidemiology, clinical aspects and antiretroviral therapy in a group of HIV (+) in Rosario City, Argentina. MATERIAL: since 1988 until 9/93 a total of 87 HIV (+) women were followed in our institution. Median age was 26 range (15-55); 16% initial stage 4 (WHO Staging System); heterosexual transmission 67%, IVDU 31%, blood transfusion 2%; married 43%, single 44%, 59% had children, 3% pregnant women; 60% male sexual partners with positive serology; median baseline CD4 count 605 range (69-1192) and baseline lymphocytes count 1848 range (456-3350). Median event times were estimated from Kaplan-Meier curves. RESULTS: heterosexual transmission 58/87 (67%) was the dominant route in our population. Nine (10%) of children had positive serology for HIV, one of them is dead. More frequent opportunistic infections more frequent were: PCP 17 (19%), Tuberculosis 8 (9%) and Cryptococcal meningitis 5 (6%). Forty-one pts received antiretroviral therapy: AZT (46%), DDI (3%) and AZT+DDC (11%), median time to treatment was 25 months (mo); estimated SV at 60 mo was: 85% and 71% (p = 0.6789) for pts with or without therapy respectively. Twenty-nine (33%) pts progressed to stage 4 with a median time to progression of 42 mo and 10 pts died; estimated probability of survival was 74% at 60 mo. CONCLUSION: 47% of patients started antiretroviral therapy due to progression of HIV infection. Heterosexual transmission was the predominant way in this population. PCP was the most frequent complication and Tuberculosis (pulmonary 3, extrapulmonary 5) was the second opportunistic infection. There was no neoplastic complications. DE Adolescence Adult Antiviral Agents/THERAPEUTIC USE Female Human HIV Infections/*EPIDEMIOLOGY/MORTALITY/TRANSMISSION Middle Age Probability Sex Behavior Survival Analysis Time Factors MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).